Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 601 - 650 out of 2,239

Document Document Title
WO/1997/003977A1
Novel 2H-3,4-dihydrothiopyrans of general formula (I) and the salts thereof, wherein R = hydrogen, C1-C8alkyl, C3-C8alkenyl or C3-C8alkynyl, n is 0, 1 or 2, are valuable microbicides. They can be used in plant protection in the form of s...  
WO/1997/003064A1
Triketone derivatives represented by general formula (I), wherein Y1 represents C1-4alkyl, halogeno or C1-4haloalkyl; Y2 and Y3 independently represent each C1-4alkyl; Y4 represents hydrogen, C1-4alkyl or halogeno; n is an integer of 0, ...  
WO/1997/001550A1
Compounds of Formula (I), and their agriculturally suitable salts, are disclosed which are useful for controlling undesired vegetation wherein Q is (Q-1) or (Q-2); R1 and R2 are each independently C1-C6 alkoxy, C2-C6 haloalkoxy, C1-C6 al...  
WO/1996/040110A1
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.  
WO/1996/041166A2
Methods and compositions are provided for determining the potential of a membrane. In one aspect, the method comprises: (a) introducing a first reagent comprising a hydrophobic fluorescent ion capable of redistributing from a first face ...  
WO/1996/040647A1
Cysteine protease inhibitors which deactivate the protease by covalently bonding to the cysteine protease and releasing the enolate of a 1,3-dicarbonyl (or its enolic form). The cysteine protease inhibitors of the present invention accor...  
WO/1996/041144A2
Fluorescent dyes which are free of aggregation and serum binding are provided. These dyes are suitable for applications such as fluorescence immunoassays, in vivo imaging and in vivo tumor therapy. Fluorescence immunoassays methods are p...  
WO/1996/040660A1
This invention encompasses compounds of formula (I) and the pharmaceutically acceptable salts thereof wherein Ar is an aryl group preferably selected from the group consisting of phenyl, 2-, 3-, or 4-pyridyl, 2- or 3-thienyl, 2-, 4- or 5...  
WO/1996/040101A1
The invention relates to the use of compounds of formula (I) wherein Ar, R, R1 and R2 are as defined in the specification, (for the manufacture of a medicament) for the treatment of a tumor selected from human breast carcinoma, lung carc...  
WO/1996/039374A1
Compounds of Formula (1), wherein Z is selected from the group consisting of the radicals shown in Formula (2) and in Formula (3), Y is cycloalkyl or cycloalkenyl of 3 to 8 carbons optionally substituted with one or two R4 groups, or Y i...  
WO/1996/036608A1
'alpha','beta'-Unsaturated ketone derivatives represented by general formula (I) or pharmacologically acceptable salts thereof, both being useful as a drug, wherein the ring moiety A represents (a), (b), (c) or (d) (wherein B represents ...  
WO/1996/030333A1
Compounds of formula (I), wherein X represents a single bond, O, S or CR9R10 where R9 and R10 each independently represent a hydrogen atom or a C1-4alkyl group; R1a, R1b and R1c each independently represent a substituent selected from: a...  
WO/1996/030368A1
Novel pyrazole derivatives represented by general formula (I) and herbicides containing the same as the active ingredient. The derivatives have a remarkably excellent crop-weed selectivity in both foilage and soil treatments.  
WO/1996/026933A1
Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibit...  
WO/1996/026200A1
The invention concerns benzoyl derivatives of formula (I) in which the substituents have the following meanings: L and M represent hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkinyl, C1-C4 alkoxy (these groups being optionally substitut...  
WO/1996/026201A1
Certain benzopyran antiestrogens are disclosed for treating estrogen sensitive diseases such as breast cancer. Prodrug forms provide ease of manufacturing, good shelf life, and bioavailibility, and preferred stereoisomers are shown to be...  
WO/1996/020186A1
A carboxylic acid derivative represented by the following general formula (I): R-CH2COOH, salts thereof, a compound that can be converted into the above compound (I) in vivo, a process for producing these compounds, and a medicinal compo...  
WO/1996/020196A1
The invention concerns novel 3-aryl-4-hydroxy-'DELTA'3-dihydrofuranone derivatives of formula (I), wherein: A and B together with the carbon atom to which they are bound form a five to seven member ring which is interrupted by at least o...  
WO/1996/020174A1
This invention relates to certain 1,3,3-(trisubstituted)cyclohexane monomers and related compounds which are useful in treating allergic and inflammatory diseases and for inhibiting the production of Tumor Necrosis Factor (TNF).  
WO/1996/019470A1
An industrially advantageous process for the preparation of a pyrazole derivative useful as a herbicide capable of dispensing with isomer separation suffering from low yield and preparation of carboxylic acid necessitating complicated st...  
WO/1996/016962A1
A process for producing pyrazole derivatives according to the reaction formula (A) wherein R1 is H or C1-C4 alkyl; R2, X1, X2, X3 and X4 are each C1-C4 alkyl; X5 is halogen; and n is 0, 1 or 2; and a process for producing an aromatic coa...  
WO/1996/014307A1
This invention encompasses compounds of formula (I) and the pharmaceutically acceptable salts thereof, wherein W, X, Y, A, and T represent organic or inorganic substituents, n is 1, 2, or 3, m is 2, 3, or 4, R1-R4 are hydrogen or organic...  
WO/1996/011686A1
Retinoid-like activity is exhibited by compounds of formula (I) where X is S, O, or NR' where R' is hydrogen or lower alkyl; R is hydrogen or lower alkyl; A is pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl or pyrazinyl; n is 0-4; and...  
WO/1996/009629A1
A composition comprising a matrix of a thermoplastic, thermosetting or a structurally crosslinked polymer, in which is incorporated an electroconductive network of crystal needles of a charge transfer complex (abbreviated to CT complex) ...  
WO/1996/008489A1
Compounds of formula (I), wherein R, R', R", Z, m, Y, n, R1, X, p and Ar have the meanings reported in the description; and pharmaceutically acceptable salts thereof are described. The compounds of formula (I) are useful in the treament ...  
WO/1996/005191A1
Compounds, methods and compositions are provided for inducing natriuresis in a mammal. Methods for isolating and synthesizing the natriuretic compounds are also provided. Therapeutic methods using the natriuretic compounds are also provi...  
WO/1996/005166A1
A substituted amine derivative represented by general formula (I), having an agonistic activity on 5-HT4 receptors, and useful as a 5-HT4 receptor agonist for preventing and/or treating diseases accompanied with the insufficiency of such...  
WO/1996/004265A1
The invention provides 2,6-dideoxy-2,3-didehydro-6-thio derivatives of 'alpha'-D-neuraminic acid. Methods for preparation of the compounds of the invention, pharmaceutical formulations comprising the compounds, and use of the compounds a...  
WO/1996/000738A1
Novel antagonists of endothelin containing an N-terminal fragment (I) are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, acute an...  
WO/1996/000214A1
Compounds of formula (I) wherein R, R1, R2 and Ar are as defined in the specification, have valuable pharmaceutical properties and are effective especially as matrix metalloproteinase inhibitors, for example for the treatment of arthriti...  
WO/1995/035286A1
Oligopeptide analogs containing sulfonamide, urea or carbamate linkages in the backbone are described. These compounds are useful in the inhibition of HIV protease, the prevention or treatment of infection by HIV and the treatment of AID...  
WO/1995/035303A1
There are described novel coupling reactions useful for the preparation of cyclitol and/or carbohydrate conjugates and carbocyclic analogs thereof. Such coupling reactions employ epoxides and/or aziridines described herein as electrophil...  
WO/1995/030644A1
Novel carbocyclic amides together with their salts, solvates and physiologically active derivatives which have a number of uses in medicine, in particular as central muscle relaxants, and in the treatment or prophylaxis of anxiety, infla...  
WO/1995/024385A1
This invention relates to a novel class of sulfonamides that are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of aspartyl protease inhibitors characterized by specific structural and physicoche...  
WO/1995/023780A2
This invention relates to compositions, compounds and methods for lightening skin, using active compounds having the structure (I) or (II) wherein: (i) each X is, independently, selected from the group consisting of halo, alkyl, substitu...  
WO/1995/019973A2
A process of preparing intermediates useful in making compounds with retinoic acid-like activity is disclosed. The intermediates are halogenated chromans and thiochromans of formula (I) shown above and are prepared by the alkylation of a...  
WO/1995/018803A1
Compounds of formula (1) where R1 and R2 are hydrogen, lower alkyl of 1-6 carbons, or halogen; R3 is hydrogen, lower alkyl of 1-6 carbons, halogen, OR11, SR11, OCOR11, SCOR11, NH2, NHR11, N(R11)2, NHCOR11 or NR11COR11; X is O, S or NR' w...  
WO/1995/014669A1
The present invention relates to novel benzenesulfonylimine derivatives and their use as inhibitors of Interleukin-1 (IL-1) action. Such inhibitors are useful in the treatment of various disease states as disclosed herein including rheum...  
WO/1995/014670A1
The present invention relates to heterocyclic benzenesulfonylimine derivatives and their use as inhibitors of Interleukin-1 (IL-1) action. Such inhibitors are useful in the treatment of various disease states as disclosed herein includin...  
WO/1995/014014A2
The present invention relates to novel tri- and tetrasubstituted pyrones and related structures which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The pyrone derivatives are useful in the development of therapies ...  
WO/1995/014013A1
The present invention relates to novel tri- and tetrasubstituted pyrones and related structures which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The pyrone derivatives are useful in the development of therapies ...  
WO/1995/014011A2
The present invention relates to novel 5,6-dihydropyrone derivatives and related structures which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The 5,6-dihydropyrone derivatives are useful in the development of the...  
WO/1995/014012A1
The present invention relates to novel 5,6-dihydropyrone derivatives and related structures which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The 5,6-dihydropyrone derivatives are useful in the development of the...  
WO/1995/012588A1
Tricyclic heteronaphthoquinone derivatives, that have antineoplastic activity, are disclosed, together with processes for their synthesis. Some of these antineoplastic compounds have a saccharide moiety. Some members of this structurally...  
WO/1995/011891A1
Compounds of general formula (I), wherein R1 is n-propyl or cyclobutyl; R2 is isopropyl, tertiary butyl, cyclobutyl, cyclopentyl or cyclohexyl; R3 is hydrogen; R4 is hydrogen or methyl; as (R)-enantiomer and in the form of free base or p...  
WO/1995/007950A1
The present invention relates to a process for the production of cyanine dyes with their methine chain showing group (M) and the charge compensation occurring by linked end groups through transformation of cationic cyanine dyes comprisin...  
WO/1995/004526A1
This invention relates generally to the field of medicinal chemistry, and more specifically to derivatives of a subclass of triterpenoid acids that have multi-medicament properties, that is derivatives of the lupane, betulinic acid, form...  
WO/1995/004054A1
A pyrazole derivative represented by general formula (I) or a salt thereof, and a herbicide containing the same as the active ingredient, wherein R1, R2, X1, X2, X3, X4 and n are each as set forth in claim 1.  
WO/1995/002587A1
Compounds of formula (I) are oxytocin antagonists useful in the treatment of preterm labor, dysmenorrhea and for the stoppage of labor preparatory to ceasarean delivery.  
WO/1995/001358A1
The invention concerns substituted spiroheterocyclic 1H-3-arylpyrrolidine-2,4-dione derivatives of formula (I) in which A and B, together with the carbon atom to which they are bound, are an unsubstituted or substituted 5- or 6-membered ...  

Matches 601 - 650 out of 2,239